More recently homozygosity of a rare variant in APOE, referred to as the Christchurch variant (R136S) was associated with long lasting protection from symptoms of AD in a single-carrier of the early-onset familial AD (EOFAD)-linked PSEN1 E280G variant [62]. Here, APOE is linked to Alzheimer disease.